Alkaloids are the most well-known cytotoxic compounds of MNPs isolated from sponges (Althagbi et al. 2020) and have established their superiority among other classes of compounds (Izzati et al. 2021). A relatively common moiety found is the β-carboline (a tricyclic 9H-pyrido[3,4-b]indole ring structure), also known as norharman (Cao et al. 2007). This unique structure also bears multiple substituents, followed by vast bioactivity arrays, as manzamine A (1) exhibited before. Previously, numerous reports investigated the effects of β-carboline alkaloids on the central nervous system (Ayipo et al. 2020), such as their affinity with benzodiazepine receptors (BZRs), 5-HT2A and 5-HT2C receptors (Dai et al. 2018). However, recent interest in these alkaloids has been focused on their potent antitumor (Ahmad et al. 2020), antiviral (Gonzalez et al. 2018), antimicrobial (Arshad et al. 2008) and antiparasitic activities (Ashok et al. 2015). In the past two decades, 80 manzamines analogs have been reported, with the possibility of more compounds remains to be characterized and studied for their bioactivity (Yousaf et al. 2004; Hamann et al. 2007). Indonesian marine sponges also contribute to add more members of manzamines and β-carboline class. In this context, fourteen of them were isolated from Acanthostrongylophora sp., consisting of five new manzamines, four typical manzamines, a dimer, and two imidazole-containing xestomanzamines (Kim et al. 2017).
Kepulauamine A (4; A549: LC50 4.6 μM; K562 LC50 7.2 μM) and manzamine J N-oxide-HCl (6; A549: LC50 4.7 μM; K562 LC50 8.1 μM) are the two most potent cytotoxic β-carboline alkaloids against adenocarcinomic human alveolar basal epithelial (A549) cell lines (Kim et al. 2017). For the inhibition of human immortalized myelogenous leukemia (K562) cells, kepulauamine A (4) was also found to be one of the most potent compounds, accompanied with 3,4-dihydromanzamine B N-oxide (5; K562: IC50 5.2 μM; A549: IC50 5.8 μM) (Kim et al. 2017). Moreover, neo-kauluamine (7; A549: IC50 13 μM; K562: IC50 12 μM) and xestomanzamine B (8; A549: IC50 12 μM; K562 IC50 13 μM) exhibited a slightly smaller cytotoxic potential, indicating the importance of appropriate substituent size and the presence of ammonium salt are essential to inhibit A549 cell lines despite the presences of their β-carboline moiety.
Two notable moieties influence the cytotoxicity of compounds (4–6), i.e., the presence of ammonium cation and oxygenated isoquinoline moiety. The influence of N-oxide on the β-carboline core is limited by the group's presence on one compound, as shown by the decreasing cytotoxicity with the removal of oxide interaction on the kepulauamine A (4). For example, the cytotoxicity of 3,4-dihydromanzamine B N-oxide (5) remarks the conjecture of K562’s sensitivity to the combination of N-oxide and epoxide moiety. This finding is supported by another N-oxide dehydromanzamines isolated from a Japanese marine sponge, Amphimedon sp., that showed the most potent inhibition on KB human epidermoid carcinoma cell lines in comparison with other compounds without the N-oxide moiety (Yamada et al. 2009). The heterocyclic N-oxide motif has proven to be a very productive emerging scaffold in drug discovery (Mfuh and Larionov 2015). Four modes of action have been proposed for this heterocyclic N–O MNPs: 1) N-oxides can elicit nitric oxide-like effects, acting as a nitric oxide agonist; 2) as bioisosteres for the carbonyl group, making these compounds strong hydrogen bond acceptor with superior enzymatic inhibitory activities; 3) as free radical sources during hypoxic-selective DNA damage; and 4) as nitric oxide donors (Mfuh and Larionov 2015).
Two new β-carboline alkaloids with a pyrimidine side chain, isolated from Acanthostrongylophora ingens, i.e., ingenine C (9) and D (10), were cytotoxic against hormone-dependent breast carcinoma cell line (MCF7), colon carcinoma cell line (HCT116), and A549 cell lines (Ibrahim and Mohamed 2016). While both compounds showed weak activity for A549 cell lines, they exhibited potent IC50 values for the two remaining cell lines. Ingenin D (10) was more active against MCF7 (IC50 2.9 μM) and HCT116 (IC50 3.3 μM) than ingenin C (9) (MCF7: IC50 4.3 μM; HCT116: IC50 6.0 μM). The relationship of the two structures and their cytotoxicity indicates that the 3-aminopropanal extension on ingenin D (10) improves the cytotoxic activity despite the similar methylamine group attached by the pyrimidine group on both compounds.
Pyridinium, Iminium, Pyridine and Pyrrole
Indonesian marine sponges also provide nitrogenous alkaloid compounds besides the exclusive β-carboline group (Althagbi et al. 2020). Two of the recent ones are haliclocyclamines C (11) and cyclostellettamines F (12), which were isolated from Haliclona sp. (Maarisit et al. 2017). The bialkylated pyridinium ion compounds 11 and 12 exhibited potential inhibition to vaccinia H-1-related phosphatase (VHR). Haliclocyclamines C (11) was reported to inhibit 28% of VHR activity at 17 μM, followed by cyclostellettamines F (12) for 38% inhibition at 18 μM. This VHR inhibiton suggests that these compounds are suitable candidates for cancer treatment medication, and for investigating the role of VHR in several cell functions ranging from cell-cycle regulation, DNA damage response, angiogenesis, platelet activation and to mitogen-activated protein kinase signaling (Pavic et al. 2015; Kim et al. 2020).
From the perspective of SAR, haliclocyclamines C (11) and cyclostellettamines F (12) show essentials structural features for the VHR binding inhibition, i.e., the two hydrophobic acyl chain moieties and the pyridinium cations. The high hydrophobicity for 11 and 12 provides a better cellular penetration (Shi et al. 2007). The binding mode could be proposed through a direct interaction between one of the pyridinium ion and the amino acid Cys124 and/or Try-128 at catalytic loop of the phosphatase (Cys124-Arg130) while the acyl chains would display hydrophobic interactions between each other and lie at the hydrophobic groove near the active site loop. This hypothesis has been demonstrated by in silico modelling through molecular mechanics calculations, energy minimization and analysis of molecular dynamics in water for a dimeric product of the antibiotic RK-682, a tetronic acid derivative and a competitive inhibitor of VHP which was isolated from Streptomyces sp. However, the binding model interaction for RK-682 and its derivatives showed that the inhibitors of VHR need a negatively charged ionic site, the tetronic acid anion with a direct hydrogen bonding interaction with the basic Arg130 residue (Usui et al. 2001).
Chloromethylhalicyclamine B (13; HeLa: IC50 6 μM) has been synthesized from halicylamine B (14; HeLa: IC50 12 μM), which was isolated from Acanthostrongylophora ingens (Esposito et al. 2016). The compounds are different by the presence of the chloromethyl group on 18 N position, affecting their inhibition activity to protein kinase enzymes CK1. The inhibition of compound 13 then was examined against various protein kinases, i.e., cyclin-dependent kinase 5 (CDK5/p25), cyclin-dependent kinase 9 and cyclin (TCDK9/cyclin T), CK1 (δ/ε isoforms), cell division control (CDC)-like kinase 1 (CLK1), dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A), and glycogen synthase kinase-3 (GSK3). However, compound 13 did not show any activity. The inhibitory potential on CK1 for compound 13 is supported by a study on a structural discovery of two hydrophobic pockets in the ATP-binding active site of CK1, which could present the most relevant binding pattern consistent with interactions for the highly hydrophobic halogen moiety at the binding pocket 01, as described by Long et al. (2012), with halogen bonding interactions of the type R–X···Y–R′, where the halogen X acts as a Lewis acid and Y can be any electron donor moiety on the protein active site (Wilcken et al. 2013), as it could happen with the amino acids Met80, Met82, and Lys38 of CK1 (Rodrigues and de Silva 2017; García-Reyes et al. 2018). Further in silico study shows that chloromethylhalicyclamine B (13) interacts with ATP-binding sites which remarks its potency as a CK1 inhibitor with ATP-competitive manner. The specific development focused on ligand–ATP competition offers a new research direction on CK1 inhibitors with the possibility of spherical compound’s class to inhibit CK1 differently than previously known planar compounds (Grieco et al. 2021).
Tetradehydrohalicyclamine B (15) was recently isolated compounds from another Acanthostrongylophora ingens together with another encounter on compound 14 (Kato et al. 2019). The absence of halogenated alkyl has been replaced by a pyridinium ion on the opposite piperidine ring of compound 15. Unfortunately, this functional group replacement did not enhance the cytotoxicity against cervical cancer cell lines (HeLa: IC50 > 50 μM). On the contrary, compound 14 was found to be a cytotoxic agent (HeLa: IC50 12 μM) on the recent assay conducted. Further studies by assessing inhibitory activity against chymotrypsin-like (CT-L), trypsin-like (T-L), and caspase-like (C-L) constitutive proteasome and each respective immuno-proteasome has shown that compound 14 is more potent on proteasomes inhibition than 15 by CT-L: IC50 1.8 µM; T-L IC50 > 15 µM; C-L: 4.7 µM on constitutive proteasome and CT-L: IC50 4.1 µM; T-L IC50 > 15 µM; C-L: 3.1 µM for immune-proteasome. Compound 14 inhibit constitutive proteasome by CT-L: IC50 0.42 µM, T-L: IC50 6.3 µM, and C-L IC50 0.48 µM, similar with its inhibition on immune-proteasome by CT-L: IC50 0.63 µM, T-L: IC50 8.0 µM, and C-L: IC50 0.44 µM. The similarity between inhibition of CT-L and C-L of 14 comes in accordance with previous finding that indicates the increase of compounds specificity on CT-L will reduce its cytotoxicity against HeLa cell line (Screen et al. 2010). Despite the small activity found on the derivatives of 14, the developed compound on the presented activities provides that the restrain of nitrogenous heterocycle backbone has also limited the compound’s biological activities.
Another form of ionic nitrogenous alkaloids has been isolated from Clathria bulbotoxa as crambescidin derivatives (Kasmiati et al. 2018). Compound (20; A431: IC50 12 nM) and (21; A431: IC50 48 nM) show the most significant cytotoxicity against the human epidermoid carcinoma (A431) cell line. The A431 cell line is more prone to 20 and 21 than other compounds without long aliphatic chains. However, the presence of a disubstituted acetamide group, as seen on the terminus group of 21, has decreased the compound’s cytotoxicity. Despite the shared hydroxide moiety on the terminus group of 20 and 21, the sensitivity of A432 cell line favors the carboxylic group on 20, which is responsible for fourfold of cytotoxicity enhancement. Furthermore, the cytotoxicity ranks linear with the length of carbon chain on the C19 and C3 or C4 for compound 19. The sequence starts with 17 (A431: IC50 0.94 μM), as the most active one with two ethyl groups attached, followed by 19 (A431: IC50 2.5 μM), 18 (A431: IC50 3.1 μM), and 16 (A431: IC50 7 μM). Despite propyl attachment on C4, compound 19 exhibited lower cytotoxicity compared to 17, suggesting that the pair of propyl and ethyl on C19 and C4 attachment has a significant effect. The comparative structures between 16–19 and 20–21 have shown that the aliphatic chain length enhances the cytotoxicity due to the permeability of a compound into the targeted animal cell (Aron et al. 2004). The presence of aliphatic chain on C14 has been extensively studied to reveals that 21 induced cell cycle arrest at G2/M phase which further decrease the cyclin D1, CDK4, and CDK6 expression on the triple negative breast cancer and luminal cancer (Shrestha et al. 2018). The addition of hydroxyl group on C13 accompanying the sidechain on C14 were also found to induces the biological activities. Crambescidin 816, which only differs on the addition of hydroxyl group on C13 from 21, has exhibited a very noticeable higher inhibition (Roel et al. 2016). The utilization of crambescidin derivatives does not only approaches on its biological potential but also on the prospective to provide active compounds through synthetic approach with 18 as the precursor core (Barbero et al. 2017).
The alkaloids with a wide variety of nitrogen substituents have been studied for their cytotoxic activity. N-methylniphatyne A (22; PANC-1: IC50 16 μM), a member of 3-alkylpyridine alkaloids, is one of the non-ionic nitrogen compounds extracted from Xestospongia sp. (Arai et al. 2016). The small of activity is then evaluated further with a new finding that compound 22 is cytotoxic against PANC-1 cell lines on a glucose deficient medium (GDM). In-depth studies on this isolate reveal two synthetic analog, compounds 23 and 24. Compound 24 showed an improvement of activity on glucose deficient medium by 8.8 μM IC50 compared to compound 23 (PANC-1 GDM: IC50 18 μM) and 22 (PANC-1 GDM: IC50 16 μM). These results indicate that the relative alkyne’s position to pyridine and N-methoxy-N-methyl terminus has slightly enhance cytotoxicity against PANC-1 cell lines.
The list of MNPs aiming for PANC-1 cell lines target is extended with another isolation of nitrogenous compound from a large-scale study involving the marine sponge, Zyzzya fuliginosa. The isolation campaign was conducted on four primary Indo-Pacific Zone, including Indonesia, resulting in the isolation of two known compounds, makaluvamine A (25; PANC-1: IC50 0.45 μM) and damirone D (26; PANC-1: IC50 3.4 μM) (Lin et al. 2017). The cytotoxicity of 25 is found to be comparable to etoposide (PANC-1: IC50 0.39 μM), a semisynthetic glycoside derivative of podophyllotoxin used in combination chemotherapies for treating lung cancer, lymphoma, and leukemia (Zhang et al. 2021b). Despite of the different location, the comparison between compound 25–26 and makaluvamine J (27) provides the essentials moiety to cytotoxicity against PANC-1 cell lines, which are possibly related with the following structural features: 1) the substituent at B-ring, 2) the presence of iminium ion on C-ring, and 3) the conjugation of fused ABC-ring (Lin et al. 2017). The difference between those three compounds has conjectured the importance of the 4-ethylphenol group as the responsible moiety for almost tenfold increase of cytotoxicity by 0.054 μM IC50 for makaluvamine J (27). Another finding also shows that the presence of diketone moiety attached to B-ring, as seen on 26, decrease its cytotoxic potential by eightfold compared to the aminoketone on 25. A pattern also emerges from the difference of nitrogen species present on the compound for its linearity with cytotoxicity. The displacement of amine on 26 with imine as seen on 25 and iminium ion on 27 shares the respective sequence of its cytotoxicity. On the specific case of fused ABC ring moiety, a high-throughput virtual and cell-based screening has provided a makaluvamine J (27) derivative which differs on three moieties, 1) replacement of 4-ethylphenol with 4-chlorobenzyl on B-ring side-chain, 2) tosyl group attachment on A-ring nitrogen, and 3) iminium ion instead of methyl iminium as found on C-ring. This derivative is found to have a potent double-inhibition activity on murine double minute 2 (MDM2) and nuclear factor of activated T cells 1 (NFAT1) oncoproteins which frequently overexpressed on pancreatic cancer (Wang et al. 2018). Another derivative with the presence of thiophen-2-ylmethyl on B-ring and imine on C-ring also shown to be potent on a non-melanoma skin cancer cell (Cowan et al. 2019). These findings further support the significance of conjugation on ABC-ring to be preserved on obtaining potent cytotoxic compounds.
The brominated alkaloids consist of a wide variety of bromoindole and bromotyrosine derivatives with various bioactivities (Ebada and Proksch 2012). Recently, bromoindole compounds 28–30 were isolated from Oceanapia sp. (Lorig-Roach et al. 2018). Compound 29 exhibits potent cytotoxicity against PANC-1 cell lines by 1.5 μM IC50. However, the accompanied compound 28 is shown to be not active despite the structural similarity. This inverse response is related to the loss of the carbonyl moiety on 28. It is also worth mentioning that from the more in-depth SAR assessment, it is found that 30, a synthetic derivative, shows less activity than the parent compound 29. This relationship indicates the importance of bromo’s position on the compound. Another interesting feature of these compounds is the presence of ammonium ion. It is similar to the previously proposed essential moiety to inhibit PANC-1 cell lines (Lin et al. 2017).
Another group of brominated alkaloids were isolated from the family Aplysinellidae (Order Verongiida) with seven new bromotyrosine derivatives out of a total of thirteen compounds (Dai et al. 2016). The isolated compounds 31–36 were assayed for their cytotoxicity against various cancer cell lines, i.e., human ovarian cancer (A2780S) with its cisplatin-resistant lines (A2780S-CP5), malignant glioblastoma (U251MG), A549, and MCF7 cell lines. The most potent cytotoxicity was displayed by compound 31, ranging between 9 to 27% of growth observed compared to dimethyl sulfoxide (DMSO) control. On the other hand, compound 32 exhibits a broader range of observed growth (60 to 111%). The key to the structure–activity relationship for 31 and 32 is focused on the different terminus groups of each compound. Compound 31 with more potent inhibition suggested that the N-terminus group plays a significant role. Guaidino moiety on the edge of compound 32 is considered responsible for its lower activity. The presence of the N-terminus on compound 34 was found to inhibit control cell lines by only 7% growth, while it inhibited cancer cell lines growth observed ranging between 14 to 71%. The unwanted cytotoxicity against normal mouse fibroblast (NIH3T3) was also found on 35 and 36 by only 25% and 29% growth, respectively. This similarity indicates that the isolated ketoxime group is essential for the compound’s cytotoxic selectivity on cancer cells (Zhai et al. 2018; Tuccinardi et al. 2013). This selectivity is also shown by compound 33 with a similar ketoxime group as compound 31 and 32. Despite the similarity, compound 33 was found to be not equally active as 31 and 32, suggesting that the combination between the direction of 2,6-dibromoanisole and the addition of dibromo methoxy benzene moiety is also significant for cytotoxicity.
Other bromotyrosine derivates, as compound 37, were isolated from the genus Hexadella and from the association of two sponges Jaspis sp. and Bubaris sp., compound 38 was obtained (Tarazona et al. 2017). Both compounds exhibited moderate cytotoxic activity against three human cancer cell lines, i.e., A549, colorectal adenocarcinoma (HT-29), and breast adenocarcinoma (MDA-MB-231). The HT-29 cell line was the most sensitive to both compounds 37 and 38 by 3.2 μM and 1.6 μM IC50, respectively. Further studies on synthetic analogs from hydrolysis of 38 have resulted in the generation of compounds 39 and 40. However, these derivatives did not show any cytotoxic activity. The remaining part of compound 38 might be related to its cytotoxicity essential pharmacophores, i.e., the presence of 2,6-dibromoanisole, carbonyl moiety on C11, and N-methylamine, which represents the distinctive structural features on compounds 37 and 38. The counter position between C9 carbonyl and 2,6-dibromoanisole is preferred to increase cytotoxicity by twofold, together with carbonyl on C11 and N-methylamine moiety. The substitution pattern of 2,6-dibromoanisole will need further evaluation, for it might be related to selectivity on different cancer cell lines. The N-terminus group discussed on compounds (31–36) also might be a subject of selectivity matters for its replacement with dimethylamine terminus on compounds 37 and 38.
Polybromo Diphenyl Ether
Besides bromoindole and bromotyrosine derivates, Indonesian marine sponges also provide polybromo diphenyl ethers compounds. These compounds are enriched with polybromo moiety attached to the phenyl substituent of the compound. The biological effect of these halogenated aromatic compounds seems to be linked to the relative hydrophobicity associated the phenomenon of halogen bonding. Transformation of bromophenols and bromoanisoles to polybrominated dibenzo-p-dioxins and hydroxy-bromodiphenyl ethers, as compounds 41 and 42, takes place by photochemical, enzymatic and surface-catalyzed reactions. Simple bromophenols with all possible substitutions can be formed by photolysis of bromodiphenyl ethers. The meta-substituted bromophenols distinguish this process from natural formation, which produces exclusively ortho- and para-substituted bromophenols (Bidleman et al. 2019). Compounds 41 and 42 were isolated from Dysidea sp. (Arai et al. 2017). These bromodiphenyl ethers were found to be active against PANC-1 cell lines in glucose deficient conditions. The isolated compounds were also potent by 2.1 and 3.8 μM IC50 for compounds 41 and 42, respectively. Although the cytotoxicity was not comparable to antimycin A (0.003 μM IC50), compound 41 was found to strongly inhibit complexes II and III in mitochondria from further examination of its mechanism of action by 0.0064 μM and 0.86 μM IC50, respectively. This evaluation also explains the cytotoxicity of 41 on glucose deficient medium by preventing cancer cell adaptation to its medium, making 41 a promising candidate for a selective anti-proliferative agent.
Terpenoids are among the second most common secondary metabolites isolated from Indonesian marine sponges after alkaloids (Izzati et al. 2021). The dominance is supported by a wide variety of terpenoids provided by the versatility of the biosynthetic pathway originating from the isoprene unit. The versatility includes the possibility of the cyclic and aliphatic compound formation with the addition of unique substituents such as halogens, a wide range of oxygenated substituents, and a wide variety of nitrogen-containing functional groups. Furthermore, as the primary source of terpenoids, marine sponges also have established their role in terpenoid-based drugs by the observed biomedical potential (Gross and König 2006; Gershenzon and Dudareva 2007; Wu et al. 2019).
A group of diterpenes has been isolated from Spongia ceylonensis. These compounds consist of seven newly isolated spongian diterpenes, 15α,16-dimethoxyspongi-13-en-19-oic acid, and eight known spongian diterpenes (El-Desoky et al. 2016) as presented on compound (43–49). Compounds 43 and 44 show the most potent inhibition for two main activities, which are differentiation of murine macrophage (RAW264) cell lines and tartrate-resistant acid phosphatase (TRAP)-positive formation of multinuclear osteoclast. These inhibitions are result from the compound's ability to decrease receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis (El-Desoky et al. 2016). This activity, unfortunately, was found to be absent for the rest of the isolated compounds. The inhibition of RANKL-induced osteoclastogenesis is proposed to be related to the amide position, as demonstrated by the inactive compound 47 when compared with the same isopentyl substituted compound 44. It also supported the comparison between 43 and 46 that shares ethylbenzene as a substituent with the same contradictive response. Herein, the alkyl attached to amide carbonyl enhance the bulkier alkyl attached to nitrogen in the γ-lactam ring, resulting in the activity to decrease in value of 13 μM; 18 μM and > 50 μM IC50 for 43, 44 and 45, respectively. It is also worth mentioning that replacing γ-lactam moiety with a furan or a tetrahydrofuran moiety shown by compounds 48 and 49, respectively, did not enhance any activities.
Further chemical studies of S. ceylonensis regarding the ability to inhibit RANKL-induced osteoclastogenesis, which provides another group of diterpene derivatives 50–52 (El-Desoky et al. 2017a). Compound 50 exhibited the most significant inhibition of multinuclear osteoclasts formation by 70% as compared to compound 51 and 52 by 28% and 31%, respectively. It is possible to draw a conjecture that the different activity is related to the conformation of ether bridge linkage and the position of the carboxylic acid substituent. The ether bridge linkage is shown to significantly improve the activity in comparison with the carboxylic acid group, as shown by compound 50 and compound 51. However, the latter exhibited comparable inhibition to compound 52 despite the different positions of the carboxylic acid substituent. Besides compound 50–52, S. ceylonensis also provides compound 53. This compound is a tricyclic diterpene equipped with an unsubstituted ring C with an aldehyde moiety. The replacement unpredictably showed an inhibition activity against USP7 with an IC50 8.2 μM (El-Desoky et al. 2017b).
The presence of carbonyl amide moiety is also found in the isolated compound from the same genus, Spongia sp. (Jomori et al. 2019), which provide three new diterpenes and one known diterpenes similar to the compounds 43–47. These recently isolated compounds 54–57 were tested for their activity against human prostate cancer (DU145) cell lines. Compound 54 showed the most potent inhibition as compared to the other three by 6.9 μM IC50. Compounds 55 and 56 were found to be inactive (IC50 > 100 μM), whereas compound 57 showed inhibition potential with an IC50 18.8 μM. These findings indicate that the orientation of carbonyl moiety is less significant than the substituent attached to nitrogen in the γ-lactam ring by the inactivity of compounds 55 and 56. In a broader comparison, the cytotoxicity against DU145 cell lines is more prone to the alkyl substitution on the nitrogen atom than the carbonyl orientation. The orientation of carbonyl was found to have more significance on the previously discussed (RANKL)-induced osteoclastogenesis.
Another presentation of a wide variety of secondary metabolites from Indonesian marine sponges is exhibited by the isolation of terpenoids with quinone moiety. This compound class belongs to the meroterpenoids compound because of its structure, which combine terpenoids and other compounds from a different biosynthetic pathway (Gomes et al. 2015). The bioactivity of meroterpenes is also varied as their structural variation. For instance, compounds 59 and 60 isolated from Dactylospongia elegans were cytotoxic against mouse lymphoma (L5178Y) cell lines (IC50 1.34 μM) (Ebada et al. 2017). Their activity is unique because both of them bear a different substituent on quinone moiety and indicate alkyl substituent's insignificance on their cytotoxicity. Compound 58, which differs from compound 60 on the position of unsaturated bond and the stereocenter of the neighboring methyl group, was 2-folds less cytotoxic (IC50 2.23 μM) than compound 60. This finding indicates that the unsaturated bond on the compound’s main skeletons is more significant against L5178Y cell lines than alkyl substituents. The comparative structure skeleton of compound (60–62) also exhibits the cytotoxic reduction by IC50 of 1.34 μM, 1.69 μM, and 6.48 μM, respectively. This trend indicates the preference for methoxy substituent compares to amine moiety. In addition, the change from primary amine to secondary amine on compounds 61 and 62 is responsible for a significant decrease in cytotoxicity, specify the preference on amine species as the substituent. This finding indicates that the hydrogen presence, which is attached to a nitrogen or oxygen atom, contributes as an essential interaction with the L5178Y cell line.
The isolated terpene quinones from Dactylospongia metachromia exhibit a similar structure to previously isolated sesquiterpene quinone derivatives (Ebada et al. 2017). The structural similarity of the isolated compounds also comes following their bioactivity. Compounds 63–67 were found to inhibit cell growth of cervical cancer cell lines expressing cell cycle maker (HeLa/Fucci2) by IC50 of 18, 16, 30, 36, and 13 μM, respectively (Hitora et al. 2021). The bioactiviy assay then proceeds by cell cycle observation. It is found that compound 67 did not show disturbance to cell cycle progression, indicating the significant role of benzoquinone and amine moiety to inhibit cell cycles despite the potent cytotoxic activity result. Furthemore, the replacement of sulfinyl with isopropyl moiety in compound 65 has decreased its cytotoxicity. The significance of sulfinyl moiety, as an important pharmacophore, is also supported by the more potent cytotoxicity of 64 as compared to the primary amine on compound 63. The sulfinyl group, possessing a high configurational stability as well as important steric and stereoelectronic differences at 64, represents an intriguing moiety of great importance for biological activity. In turn, sulfoxides are also among various biologically active compounds, including medicines such as omeprazole or sulforaphane (Kiełbasiński et al. 2019).
A wide variety of quinone terpenoids is also represented by the xestoquinones. This iquinone-related secondary metabolites consist of 16 new derivatives (Tanokashira et al. 2016). The compounds comprise trimeric structures, such as compounds 68 and 2, dimeric structures, as compounds 3, 69, and 70, and its monomeric units—compound 71, in which all are equipped with notable activity. The compounds were found to inhibit the activity of the USP7 enzyme, which is related to various types of cancer (Wang et al. 2019; Li and Liu 2020). Compound 71 showed the most potent activity (IC50 0.13 μM) followed by compound 3, 69, and 70 with IC50 0.35; 0.47; and 0.49 μM, respectively. The least active of the top five compounds was the trimeric xestoquinone, compound 68 (IC50 0.75 μM). However, compound 2 exhibited inhibition activity for USP7 on the dimeric region (IC50 0.36 μM), comparable with compound 3. This result suggests that USP7 will react with the unsubstituted position of quinonoid (C-14 and C-15) by any thiol moiety of the enzymatic target (Wang et al. 2011). Besides the previous discussion of the occupancy of C-14 and C-15 positions on compound 2, the dimeric structure of petroquinones also exhibits a unique chemical feature. A longer bridge or flexible linker between the monomer unit will lower its potential on USP7 inhibition as seen on compound 70. This low activity might be related to both C15 and C15' unsubstituted position similar to C-14 and C-15' in compound 3. Besides the unsubsituted C-14 and C-15, the inhibition might be affected by the orientation of the monomer units. However, the orientation on the dimeric 69 shows an enhancement for almost twofold on USP7 inhibition due to a hindered rotation about a single bond as compared with the free rotation in compound 70. This differentiation suggests that further studies are required to investigate the mechanism of USP7 inhibition involving a specific orientation of the monomeric units.
Besides quinone moiety, MNPs from Indonesian sponges also brought various compounds that bear a carbonyl on a terpene backbone, such as acetylenic acid, galactoside triterpenes, and furanosesterterpenes. One group of the isolated compound belongs to acetylenic derivatives, cinachylenic acids A-D (72–75) (Mokhlesi et al. 2017a). These compounds were isolated from the genus Cinachyrella and show potent activity against L5178Y cell lines. The activity is comparable to a well-known cytotoxic compound, kahalalide F (IC50 4.3 μM), whereas compounds 72–75 showed IC50 \(\cong\) 0.3 μM. The inhibition was proposed to correlate between unsaturated chains with the permeability of a compound into the targeted cells as presented by quinones (Aron et al. 2004; Kasmiati et al. 2018). On the other hand, cinachylenic acids A-D (72–75) and compounds 58 and 60 share the presence of a methoxy functional group. These findings indicate that the unsaturated chain and the methoxy group equipped the compounds with hydrophobic properties to facilitate cell-permeability.
Furthermore, two terpenoids with galactoside moiety, melophluosides A (76) and B (77), were identified from Melophlus sarasinorum (Sadahiro et al. 2020). Cytotoxic assay of the isolated compounds showed that melophulosides A and B have weak sensitivity to HeLa cell lines. The comparative result exhibits an enhancement on the presence of acetoxy group on melophulosides B (77), which could be related to a higher lipophilicity, from hydroxyl and methyl group on melphulosides A (76) with IC50 values of 9.7 and 11.6 μM, respectively. In addition, meluphulosides A and B show comparable inhibition to the same target as shown by compound 14 and compound 67, which belongs to pyridine-bearing alkaloids and a quinone terpenoid, respectively. These pieces of information indicate that pyridine and the enrichment of the carbonyl functional group have an irrelevance effect for the cytotoxicity enhancement and non-selective sensitivity on HeLa cell lines.
The variety of carbonyl-bearing terpenoids also presents a unique structure combination between furan and carbonyl attachment to a terpene skeleton which belongs to furanosesterterpenes compounds. For example, the compounds isolated from Psammocinia sp. (Afifi et al. 2017) show moderate activity against the USP7 enzyme related to the various types of cancer. The inhibition activity is presented as IC50 values of 2.8; 4.6; 2.7; and 3.5 μM for compound 78–81, respectively. All compounds are cytotoxic with a similar potency. No conclusion could be obtained. It seems that the pharmacophore is related to the unsaturated lactone. Furans are non-polar, and the ether oxygen adds a potential for effective hydrogen bonding interactions with target enzymes (Banerjee et al. 2012).
Besides the possibility of furan and lactone significance, the similar activity exhibited by compounds 78 and 80 also shows the insignificance of methyl addition on the cyclopentenone–furan connection. The preference of significant functional groups then emerges from the terpene backbone. The E and Z on configuration difference are similar to the previously discussed acetylenic acid derivatives compound 72–75, where E configuration on C12 favors cytotoxicity. The compound 78–81 configuration shows the selective sensitivity of USP7 to the double bond configuration and adds further supports to the significance of monomer orientation of USP7 inhibitor.
Peptides or oligopeptides are well-known bioactive MNPs from sponges, consisting of relatively small number of amino acid residues in either a cyclic or straight formation. This class marked its bioactive debut with the isolation of discodermin A from the sponge Discodermia kiiensis, which bears antibacterial activity (Matsunaga et al. 1984; Ebada and Proksch 2012). A recent review reported that peptides from marine sponges had established their role as an antifungal, anti-inflammatory, and antiviral agents, and their future as important scaffolds for the development of anti-cancer agent (Xie et al. 2020; Zhang et al. 2021a).
Indonesian marine sponge is a promising source of cytotoxic peptides since about 20 compounds have been isolated from 1970 to 2017 (Hanif et al. 2019). One of the recent compounds is daedophamide (82) which was isolated from Daedalopelta sp. (Urda et al. 2017). This cyclodepsipeptide consists of multiple amino acids and a "ring" connected by at least one peptide bond, an amide type (Lee et al. 2017). The ester bond of daedophamide (82) is formed between the carbonyl group of pipecolic acid (l-Pip) and the nitrogen of the threonine residue (Thr). The "ring" possessed by 82 is connected through the amino terminus of threonine and a β-hydroxy group of 3,4-dimethylglycine (3,4-diMeGln). This novel compound possesses a complex structure and strong activity against four human tumor cell lines, i.e., MDA-MB231, HT-29, A549, and human pancreas carcinoma (PSN-1) cell lines. The inhibition activity of 82 is strong and comparable to doxorubicin, i.e., IC50 0.3; 0.6; 0.4; and 0.2 μM for daedophamide and IC50 0.3; 0.2; 0.2; and 0.2 μM for doxorubicin, respective, to each tumor cell lines.
Other cyclopeptides isolated from Clathria basilana, i.e., microcionamide C (83), microcionamide D (84), and microcionamide A (85), have a disulfide linkage between two cysteine residues, forming a hexapeptide ring (Mokhlesi et al. 2017b). Compounds 83–85 exhibit strong cytotoxicity against A2780, leukemia (HL-60, Nomo-1, and Jurkat J16), and lymphoma (Ramos) cell lines. The inhibition is decreasing from 83, 84, to 85 with only a slight difference between 83 and 84. The E or Z conformation of 2-phenylethen-1-amine (PEA) on l-Cys1 residue is less significant compared to terminal Ile (extension on R2) that favors ethyl rather than methyl with IC50 values of 0.45; 0.43; and 2.6 μM on A2780 cell lines for compound 83–85, respectively. The trends also supported by further assessment that 83–85 are able to activate the caspase-3 protein which leads to apoptosis. However, microcionamide A (85) is found to be not active to inhibit autophagy unlike 83 and 84 which bears an ethyl extension on R2 in comparison with the methyl substituted compound as seen on 85.
As another addition to the list of cyclopeptides, compounds named carteritins A (86), phakellistatin 13 (87), and hymenamides C (88) were isolated from Stylissa carteri (Afifi et al. 2016). The distinctive feature of these cyclopeptides is its enrichment of proline residues as present on 86 which is parallel with the activity of the compounds against three cancer cell lines, HeLa, HCT116, and RAW264. On the other hand, despite the minor proline moieties present on 87, the compound exhibits notably selective and moderate cytotoxicity against HeLa by 15 μM and is considered inactive (> 50 μM) against HCT116 and RAW264. In terms of selectivity, compound 88 exhibits potent cytotoxicity against HCT116 by 5.0 μM compared to 25 μM for HeLa cell lines and considered inactive against RAW264. The similarity of two proline residues on 87 and 88 might be the trade for selectivity. The selectivity of 87 and 88 might be related to the difference in replacement on threonine residue on 87 to glutamine residue on 88 added with the cis- and trans-proline conformation between phenylalanine and tryptophan residue.
Jaspis splendens provides cyclic and acyclic cyclodepsipeptide, jasplakinolide (89), ( +)–jasplakinolide Z6 (90), ( +)–jasplakinolide Z5 (91), and ( +)–jasplakinolide V (92) (Ebada et al. 2019). Some of the isolated compounds showed nanomolar cytotoxicity against L5178 cell lines with an IC50 < 100 nM for compounds 89, 91, and 92. On the other hand, ( +)–jasplakinolide Z6 (90) showed a lower cytotoxicity (IC50 3,200 nM). These findings conjecture a relationship between the presence of carboxylic acid terminus on the acyclic form, presented on ( +)–jasplakinolide Z6 (90) and the registered cytotoxicity in the L5178Y cell line inhibition.
Some polyketides have also been recently isolated from Indonesian marine sponges. For example, biakamides A − D (93–96) were isolated from the marine sponge Petrosaspongia sp. and exhibited growth inhibition against PANC-1 cell lines with IC50 values of 1.0, 4.0, 0.5, and 0.5 μM for compounds (93–96), respectively, on glucose deficient medium (Kotoku et al. 2017). Further assessment on their mechanism of action, compound 95 shows selective inhibition to complex I in the mitochondrial electron transport chain. From the SAR point of view, it is shown that the presence of 3-methoxy-2-butenoyl is more significant than the E or Z conformation. In terms of selectivity, compound 95 did not show inhibition against complex II and III in mitochondria to prevent cancer cell growth in vitro.
Target-Based Structure–Activity Relationship
The exposition of SAR on each compound class could be extensively discussed based on their activity. This extended exposition is useful to accommodate the demand for a selective drug from the source and segregated by its targeted cell lines. In this section, we attempt to provide a paper-to-paper comparison to highlight the often-neglected cytotoxicity from one finding that might be a helpful comparison to another in obtaining a comprehensive SAR study.
PANC-1 Cell Line
The lead compounds with cytotoxic against PANC-1 cell lines, in a nutrient-deprived conditions, are mostly polyketides represented by biakamides, such as 93–96. Compared with polybrominated diphenyl ethers 41–42, most of biakamides showed a decreased cytotoxicity except for biakamides B (96), although both groups contain the halogen group. The position of halogen attached on biakamides was shown to be less significant than the terminus group. The synthetic molecules, compounds 97–100, which are a member of tetrahydroquinolin-2(1H)-one derivatives, exhibited a moderate inhibition with IC50 values of 5.2, 4.9, 7.7, and 7.7 μM, respectively (Shen et al. 2019). Several main moieties are suggested to affect PANC-1 cell line inhibition in a nutrient-deprived conditions. One of them is the presence of the terminal heterocycle moiety, including furan on 97, thiophene on 98, thiazole on 93–96, or pyridine on 22–24. Thiazole moiety on the heterocycle bearing compound provides the most significant cytotoxicity as presented by the biakamides 93–96. The preference of heterocycle moieties is followed by thiophene on 98, furan on 97, and pyridine on 22–24. The significance of heterocycle moiety as a pharmacophore for the cytotoxicity is represented by the lower IC50 on cytotoxicity of compounds 99 and 100 and exemplified by previous report on synthetic SAR study on the coumarin substituted hydrazide–hydrazone derivatives. The SAR study concludes that the occurrence of the furan terminus group or other heterocycles is enhancing the cytotoxicity against PANC-1 cell lines (Nasr et al. 2014; Hu et al. 2021). The ability of heterocycles to engage in a wide variety of intermolecular interactions, including hydrogen bond donor/acceptor capability, pi-stacking interactions, metal coordination bonds as well as van der Waals and hydrophobic forces, allows them to bind in a multitude of ways. In addition, their wide range of ring sizes and structural permutations means heterocycles come in a broad range of shapes and sizes, allowing them to match the equally diverse structural range of enzyme binding pockets on cancer cell lines (Tandon et al. 2019). The second essential moiety for cytotoxicity is the presence of the carbon chain. The preference for more extended alkyl chain moiety is found on three cytotoxic compound groups, which are biakamides 93–96, synthetic tetrahydroquinolin-2(1H)-one derivatives 97–100, and 3-alkylpyridine alkaloids 22–24. The presence of the carbon chain moiety is presumed to correlate with their lipophilicity and the resulting ability for cellular penetration (Aron et al. 2004; Wojcieszak et al. 2018). In addition to carbon chain moiety, the acetamide moiety plays a significant role in cytotoxicity against the PANC-1 cell line on nutrient-deprived conditions. Acetamide’s presence on the cytotoxic compounds follows the trends as it is absent on the compound with lower cytotoxicity, i.e., the 3-alkylpyridine alkaloids 22–24 and the polybrominated diphenyl ethers 41–42. Last, the terminus or near terminus hydroxide group is also an essential moiety. The hydroxyl group follows the same trend as the acetamide group on the compounds with a higher cytotoxic potential.
On the other hand, the cytotoxicity assay against PANC-1 cell lines with normal nutrient conditions showed that makaluvamine J (27) and daedophamide (82) had submicromolar value, (IC50 0.054 and 0.2 μM, respectively). The SAR evaluation of the PANC-1 cell line is also provided with synthetic peptides originating from marine cyanobacteria, majusculamide D (101) (Caro-Diaz et al. 2019). The synthetic compound has a sub-nanomolar IC50 (0.32 nM) compare to the sub-micromolar IC50 for daedophamide (82). The remarkable cytotoxicity shown by majusculamide D (101) is obtained from the presence of an alkyl chain, an oxygenated aromatic, and N-methylated amides. The significance of N-methylated amide on peptides has been reported to enhance its membrane permeability, proteolytic stability, and solubility which also increases its oral bioavailability (Chatterjee et al. 2008; Northfield et al. 2014; Wu et al. 2021). The conjecture of the three significant moieties on cytotoxicity against PANC-1 brings possible activities from jasplakinolide (89), ( +)–jasplakinolide Z5 (91), and ( +)–jasplakinolide V (92), which bears oxygenated aromatics and alkyl chain. The free secondary-amine will cause the only predicted hindrance on the compound’s bromoindole moiety and peptide chain section.
Makaluvamine J (27) also possesses oxygenated aromatic moiety and proceeds to show its submicromolar cytotoxicity despite the neighboring free secondary amine group. In the comparison between makaluvamine J (27) and makaluvamine A (25), which presented with methylated nitrogen and primary amine as a replacement for the oxygenated aromatics, the methylated nitrogen is less significant than oxygenated aromatics moiety for its almost tenfold decrease of cytotoxicity. An overview of cytotoxicity against PANC-1 cell line on normal nutrient and nutrient-deprived conditions shows that the cell line is sensitive to a heterocyclic moiety on the terminus position as shown by majusculamide D (101), biakamides 93–96, and the synthetic tetrahydroquinolin-2(1H)-one derivatives 97–100.
A549 Cell Line
The lung carcinoma cell lines (A549) emerge as one of the most targeted cell lines from recent studies on cytotoxicity of MNPs from Indonesian sponges. The cytotoxicity against the A549 cell line is led by a peptide, daedophamide (82) and followed by the bromotyrosine derivatives, anomoian B (37) and aplyzanzine B (38) with IC50 values of 0.4, 5.1, and 6.1 μM, respectively, against A549 cell lines. Concern also arose for the LC50 value of daedophamide (82). The narrow range between IC50 0.4 μM and LC50 0.7 μM should be concerned because it will be affecting the development of daedophamide (82) as a future drug. Recently, Abdel-Rahman and colleagues has conducted a study on cyclohepta[b]thiophenes derivatives against various cancer cell line. From the study, one compound exhibited a wide range cytotoxicity against colorectal cancer cell line (COLO) (3.07 μM IC50; 76.30 μM LC50). Furthermore, the studied compound also shows a reduction in tumor growth and stable body weight on animal studies with human xenograft tumor. This study implies the needs of appropriate range between IC50 and LC50 to provide efficacy and safety on the in vivo study (Abdel-Rahman et al. 2020). On the same case, the LC50 data shows potential for kepulauamine A (4) and manzamine J N-oxide-HCl (6), which show a concerning activity by 4.6 and 4.7 μM, respectively.
In bromotyrosine derivatives, such as psammaplin A monomers (102) and its analogs (103) (Baud et al. 2012; Bao et al. 2021), significance for the cytotoxicity effect of the free ketoxime group over the dimethylamine on 37 and 38 is evident. Besides the free ketoxime group, the cytotoxicity against the A549 cell line also leans towards a more straightforward structure of bromophenol in comparison to dibromomethoxyphenol moiety as present on 31 and 32.
Breast Cancer Cell Lines
A few breast cancer-related cell lines are used on the cytotoxicity assay of recently isolated MNPs from Indonesian marine sponges, including MDA-MB-231, MCF7, and trastuzumab-resistant human epidermal growth factor 2 positive (HER2 +) cell lines. The recently extracted sponge, Aaptos suberitoides, shows a promising inhibition against HER2 + cell lines with IC50 12 ppm (Bashari et al. 2021). As the recent studies already reveal the potential cytotoxicity of Indonesian marine sponge, further research on compound isolation will provide remarkable benefits to obtain comprehensive comparison on the isolated compounds.
Daedophamide (82) is a lead compound from the Indonesian sponge that shows breast cancer inhibition (Table S1). The list then followed with bromotyrosine derivatives, compound 37 and 38, which show the same pattern from previously discussed cell lines. Despite the similar value of IC50 shown by β-carboline derivatives, compounds 9 and 10, the cytotoxicity is unfitted to be compared directly because different breast cancer cell lines, i.e., MCF7 and MDA-MB-231, were assayed. The difference between MCF7 and MDA-MB-231 lies in the enrichment of Ki67-antigen on the cell lines. The presence of Ki67 on the MDA-MB-231 remarks the aggressiveness and increase on cell migration of the cell lines compared to MCF7, classified as low-Ki67 cell lines (Holliday and Speirs 2011; Yuan et al. 2016). Nevertheless, the comprehensive comparison of the listed compounds is still limited. For instance, compounds 31–36 only include percent of observed growth against MCF7 cell lines, although they show an attractive feature in terms of selectivity. On the other hand, the compound araplysillin VII (34) with a distinctive guaidino terminus and isoxazole moiety displayed a higher potential on the percent of growth observed against MCF7 than A549 cell lines. This finding indicates that the MCF7 cell line is more prone to the isoxazole moiety than the free ketoxime.
HeLa Cell Line
HeLa cell line is the first continuous cancer cell line and one of the most commonly used cell lines among many disciplines (Masters 2002). One of the studies representing the intersection between HeLa cell lines and MNPs from Indonesian sponges is the study of Xestospongia testudinaria extract. Through the MTT assay, the partitioned-methanolic extract showed potent activity against the HeLa cell line with IC50 value of 2.273 ppm (Swantara et al. 2019). The obtained inhibition represents the potential of the Indonesian marine sponge as a promising source for cytotoxic MNPs (Table S1). The HeLa cell line inhibition by the isolated compounds is led by a peptide, carteritins A (86), with IC50 of 0.7 μM. On the other hand, hymenamides C (88) and phakellistatin 13 (87) are listed with a significantly lower activity with IC50 of 15 and 25 μM, respectively. Besides peptides, the galactoside-triterpenes show a tenfold decrease in activity for both melophluosides A (76) and B (77).
On a broader view, comparison with synthetic derivatives of diaminoindoloylthiazoles (104; HeLa IC50 1 μM) and thiopyranopyrimidine derivatives (105; HeLa IC50 0.104 μM) were included as a SAR benchmark on HeLa cytotoxicity (Juneja et al. 2013; Zhao et al. 2020). The two nitrogen atoms and indole group on both compounds are essentials to provide bidentate hydrogen bonding and increase binding affinity, respectively. In addition, the presence of an extended acrylamide group avoids unnecessary binding to non-target proteins which reduced the potential side effects. The avoidance is provided by increasing binding affinity to the Cys797 residue on the epidermal growth factor receptor (EGFR) signaling pathway on HeLa cell line. The combination of these moieties resulted in tenfold increase of cytotoxicity against HeLa (Zhao et al. 2020). However, the isolated compounds from Indonesian marine sponges that are assayed against HeLa does not contain these moieties, except the potent carteritins A (86).
A2780 and Related Cell Lines
The search for another therapeutic agent for ovarian cancer is imminent for its recurring possibility and low survival rate (McClung and Wenham 2016; Erba et al. 2001). The famous A2780 cell line MNP inhibitors are the ecteinascidin-743 (ET-743) (106) (Erba et al. 2001) which is marketed as Yondelis® originated from tunicates and gukulenin A (107), from the marine sponge, Phorbas gukhulensis (Ahn et al. 2019). Despite the different geographical origins, these compounds have shown remarkable cytotoxicity against the A2780 cell line and marked their way of being the candidate for cancer therapeutic options. Another contribution that can be taken from these compounds is the essential functional group or a specific moiety to be compared with Indonesian origin MNPs. Ecteinascidin-743 (ET-743) (106) and gukulenin A (107) stand as the leaders on the list with a more than tenfold increase in cytotoxicity as compared to other Indonesian isolated compounds. On the Indonesian sides of the list, the cytotoxicity is led by peptides represented by microcionamide C, D, and A (83–85), followed by the bromotyrosine derivatives (31–36).
Despite being found as the less cytotoxic compounds from Indonesian marine sponges, the bromotyrosine derivatives also provide a selectivity feature on the compound tested. A few compounds which show inhibition against normal mouse fibroblast (NIH3T3) is eliminated from the potential category, resulting in purpuramine M (31) with IC50 20 μM as a promising candidate. In addition to the selective screening of activity, the research also provides an IC50 40 μM value for A2780-CP5 cell line of 31. This early screening will be beneficial for further development of 31 as a drug candidate and further SAR study on MNPs for their activity against the A2780 cell line, especially for the cisplatin-resistant cell lines (Table S2).
Colorectal Cancer Cell Lines
The HT-29 and HCT116 cell lines are well-known in the race to obtain new therapeutic strategies in fighting one of the most commonly diagnosed cancers considering their development of metastases and their low 5-year survival rate (Xu et al. 2020). On MNPs from Indonesian sponges, a few candidates with promising activity on inhibiting HT-29 and HCT116 cell lines are listed in Table S2. The isolated compounds consist of peptides, β-carboline, and bromotyrosine derivatives. Peptides lead the list with an interesting competition between daedophamide (82) and the smaller size, carteritins A (86), phakellistatin 13 (87), and hymenamides C (88). However, both group’s IC50 values cannot be compared directly for the different aggressiveness between HT-29 and HCT116 cell lines. The HT-29 cell line is known for its ability to differentiate, compared to the HCT116 cell line, which is more aggressive with non-differentiating growth (Yeung et al. 2010; Olejniczak et al. 2018). The less aggressive HT-29 cell line is more prone to large peptides (Table S2), daedophamide (82) with an IC50 value of 0.6 μM. This activity is still considered promising as compared to its positive control doxorubicin (IC50 0.3 μM), despite the twofold increase in activity. Besides the peptides, the HT-29 cell line is also shown to be sensitive to the bromotyrosine derivatives, aplyzanzine B (38) and anomoian B (37), which contrast with its low cytotoxicity against A549 cell lines. For its possibilities in selective inhibition of colorectal cancer cell line, it is interesting to further examine these bromotyrosine derivatives on the HCT116 cell line. The same prediction is also applied to reverse the scenario for peptides, carteritins A (86) and hymenamides C (87), on their inhibition against HT-29 cell lines. This predictive examination will be beneficial to obtain the selectivity and mechanism of action for both compounds and the cancer cell line target.
The emergence of β-carboline derivatives on the list also put another interesting attention. The compounds ingenine C (9) and ingenine D (10) showed moderate activity against the HCT116 cell line with IC50 of 2.90 and 3.35 μM, respectively. A different study suggests that manzamine A (1), another β-carboline alkaloid, also shows similar cytotoxicity against the HCT116 cell line with IC50 of 4.5 μM and 10 μM against HT-29 cell line (Lin et al. 2018). These results suggest that the HCT116 cell line is more prone to β-carboline moiety than the HT-29 cell line. Another SAR study also braces the ideas on the significance of appropriate substituent on C1 to enhance the cytotoxicity of β-carboline compounds on various target cell lines (Dai et al. 2018; Aaghaz et al. 2021).
L5178Y Cell Line
The recently isolated peptides lead the list of cytotoxic compounds against mouse lymphoma cell lines (Table S3). A feature worth mentioning is the efficacy as cytotoxic agents of cyclic compounds compared to acyclic compounds. This feature marked by the leading the acyclic jasplakinolide (89) and ( +)–jasplakinolide V (92) followed with the cinachylenic acid A-D (72–75) with the possession of a straight chain. However, ( +)–jasplakinolide Z5 (91) displayed a similar cytotoxicity against the L5178Y cell line despite the acyclic form. This finding reduces the significance of the cyclic form in comparison with the carboxylic acid moiety presented by ( +)–jasplakinolide Z6 (90), which was supposed to lower the cytotoxicity. This speculation comes in accordance with a previous study on jasplakinolides family with similar cytotoxicity observed for both acyclic and cyclic members. Further assessment on the jasplakinolides has brought to attention the acyclic compound for a specific activity as stabilizers of filamentous-actin (F-actin) on the cytoskeleton of HCT-116 cells. The F-actin stabilization believed to cause the disruption of the actin cytoskeleton on the colon cancer cell tested on the acyclic compound. However, the acyclic members that contains carboxylic acid and hydroxide terminus, similar to 90, were not active (Watts et al. 2011).
Inhibition on Cellular Processes
The attention to the cytotoxicity of MNPs, mainly Indonesian marine sponges, is also shown to inhibit various non-cell targets. The non-cell target assay is mainly conducted by inhibiting cell process-related targets such as USP7, VHR, and RANKL-induced osteoclastogenesis. The USP7 inhibition (Table S3) is led by xestoquinone (71), dimeric- (3, 69, and 70), and trimeric- (68 and 2) form of xestoquinone and followed by the furanosesterterpenes (78–81). It is previously discussed that the inhibition of USP7 is closely related to the unsubtituted position of the quinonoid moiety. This supposed relationship is counteracted with a slightly similar unsubstituted position on the α-carbon atom presented by furan moiety on compound (78–81) for their marginal IC50 value compared to petroquinone A (68). This finding indicates that the USP7 is specifically sensitive to an unsubstituted position of α-carbon atom on quinonoid. Another interesting comparison is shown by the emergence of ent-13-norisocopalen-15-al-18-oic acid (53), which contains aldehyde terminus. Compound 53 shows a slightly small inhibition against USP7 with an IC50 8.2 μM. Its low cytotoxicity might be related to the presence of the fused cyclohexane towards the aldehyde moiety. This finding is supported by a recent review that discusses formaldehyde's reactivity towards cysteine, producing disruption on disulfide linkage and possibly inhibiting USP7 as a member of cysteine protease (Kamps et al. 2019).
The non-cell target inhibition also covered the RANKL-induced osteoclastogenesis. This inhibition of RANKL production is rationalized by the possibility of cancer cells that developed into bone metastasis. Despite the lack of cytotoxicity against its cancer cell line, the inhibitor of RANKL-induced osteoclastogenesis can decrease the bone destruction rate (Bi et al. 2017). This inhibitory activity is shown by cylonamides A–C (43–45) and ceylonins A, D, and F (50–52). One of the most promising candidates was ceylonamides A (43) with an IC50 value of 13 μM. This finding indicates the sensitivity of RANKL-induced osteoclastogenesis towards meroterpenes amide with ethylbenzene attachment to the nitrogen atom.